Salvianolic acid A positively regulates PTEN protein level and inhibits growth of A549 lung cancer cells
Author(s) -
Lei Bi,
Jianping Chen,
Xiaojing Yuan,
Zequn Jiang,
Weiping Chen
Publication year - 2012
Publication title -
biomedical reports
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.607
H-Index - 25
eISSN - 2049-9442
pISSN - 2049-9434
DOI - 10.3892/br.2012.33
Subject(s) - pten , oncogene , molecular medicine , cancer , cancer research , cell cycle , lung cancer , apoptosis , a549 cell , cell growth , biology , microbiology and biotechnology , chemistry , medicine , biochemistry , genetics , pi3k/akt/mtor pathway
Salvianolic acid A (Sal A) is an effective compound extracted from Salvia miltiorrhiza which has been used in the treatment of various diseases. Preliminary data indicate that Sal A treatment has a specific anti-lung cancer effect. However, the manner in which Sal A regulates cancer growth remains unknown. In this study, the A549 lung cancer cell line and its response to Sal A treatment was examined. Results showed that Sal A treatment significantly decreased A549 cell growth, promoted partial apoptosis and increased mitochondrial membrane permeability. Western blot analysis showed that Sal A upregulated the phosphatase and tensin homolog (PTEN) protein level, while consistently downregulating Akt phosphorylation. These results indicate that Sal A negatively mediates A549 lung cancer cell line growth or apoptosis, most likely by positively regulating PTEN protein level.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom